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ABSTRACT
Background: Staphylococcus lugdunensis is a coagulase-negative staphylococcus (CoNS) that is
a part of the normal human skin flora. Even though it belongs to CoNS family, it can cause
severe and destructive infections in a similar fashion to Staphylococcus aureus. Skin and soft
tissue infections (SSTI), bacteremia and endocarditis are amongst the most common clinical
presentations. Diagnosis and clinical presentation of infections caused by S. lugdunensis in
cancer patients is limited.
Materials and Methods: We performed a retrospective chart review of 24 patients who had
cultures positive for S. lugdunensis. Out of 24 patients, 14 patients were diagnosed with a true
infection and 10 other patients were considered to be colonized with this pathogen. We
analyzed clinical manifestation, treatment and response to therapy.
Results: SSTI was the most common presentation in our study patients. All patients
diagnosed with SSTI had a prior surgery or an invasive procedure at the affected site. Five
urinary tract infections (UTIs), one catheter-associated bloodstream infection, and a deep
pelvic abscess were other reported infections in our study. We observed that S. lugdunensis
remains susceptible to a variety of antibiotics, with all isolates susceptible to vancomycin
and linezolid and most remain susceptible to fluoroquinolone and trimethoprim/
sulfamethoxazole. All 14 patients received antibiotics and improved.
Conclusions: In our case series, SSTI was common and diagnosed in 50% of the patients with
clinically significant isolates for S. lugdunensis. This is consistent with prior studies indicating
that S. lugdunensis is a significant pathogen in SSTIs. UTI was the second most common
infection type in our patient population.
Keywords: Staphylococcus lugdunensis; Coagulase-negative Staphylococcus; Bacteremia; Infection;
Cancer
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INTRODUCTION
Staphylococcus lugdunensis is a coagulase-negative staphylococcus (CoNS) that is a part of the
normal human skin flora. Even though it belongs to CoNS family, it is known to cause more
severe infections in a similar fashion to Staphylococcus aureus [1-3]. Therefore, isolation of this
pathogen on culture should be considered as a true pathogen, rather than a contaminant,
especially if isolated from sterile site cultures. It is a known etiology of skin and soft tissue
infections [4], bacteremia and native valve endocarditis [1, 5]. Other sites of infections
caused by S. lugdunensis include bone and prosthetic joint [6], catheter and other deviceassociated infections, as well as the central nervous system [2, 7]. It is unusual to cause
urinary tract infection [2, 8].
The available data on the diagnosis and clinical characteristics of S. lugdunensis infection
in patients with underlying malignancy is limited. Nesher et al. recently published a
retrospective review of 45 cases from a comprehensive cancer center and studied the
characteristics of S. lugdunensis infections in cancer patients[9]. Skin and soft tissue
infections were the most common entities; a significant number of patients had a history of
surgical procedures or an implanted medical device [9]. Noguchi et al. made an interesting
observation that group D clones of S. lugdunensis may be associated with colon carcinoma
[10]. However, S. lugdunensis is not well studied in cancer populations.
The objective of this study was to better understand and recognize the infection caused by
S. lugdunensis in cancer patients.

MATERIALS AND METHODS
We retrospectively reviewed all patients with cultures positive for S. lugdunensis between
January 2000 and January 2018 using the H. Lee Moffitt Cancer Center and Research Institute
institutional database system. Inclusion criteria for chart review were adults above age 18 who
had a positive culture (blood, urine, wound, abscess, cerebrospinal fluid) for S. lugdunensis.
All culture samples were analyzed in the microbiology laboratory at the Moffitt Cancer
Center and organism identification was performed through standardized microbiological
testing methods: first, we perform coagulase test which will be negative, then we use
VITEK2 machine with the GP ID Card (BioMerieux, Durham, NC, USA). An automated
culture method was used to confirm the identification and susceptibilities of S. lugdunensis.
General patient characteristics including age, gender, and underlying cancer diagnosis were
included in the analysis. Patient cases were classified into either having a true S. lugdunensis
infection versus a colonization/contamination when positive culture for S. lugdunensis was not
considered to be clinically significant. For body fluid aspirates or wound cultures positive for
S. lugdunensis, a true infection was diagnosed when local (e.g., erythema, wound drainage)
and/or systemic symptoms (e.g., fever, leukocytosis) were present in addition to a positive
culture. For urine cultures positive for S. lugdunensis, a true infection was diagnosed when
urinary symptoms (e.g., frequency or burning with urination, hematuria) were present in
addition to a positive culture. A true infection of the bloodstream or central nervous system
was suspected only when clinically relevant symptoms were present in addition to a positive
culture. Informed consent was waived due to the retrospective nature of this work and deidentified chart review. The methods of this study were approved by the University of South
Florida Institutional Review Board (Approval #: Pro00034756) and Moffitt Cancer Center
https://icjournal.org
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Scientific Review Committee. Quantitative description was used for summarizing the data.
Microsoft Excel (Sacramento, CA, USA) was used to summarize data in mean (± standard
deviation) or number (percentage).

RESULTS
A total of 24 patients had a positive culture for S. lugdunensis at the H. Lee Moffitt Cancer
Center and Research Institute within the study period. General characteristics of the
patients are shown in Table 1. The ages of the patients ranged between 29 to 79 years
(Mean age 60.9 ± 12.4 years). Thirteen patients were male and eleven patients were female.
Underlying malignancies were also analyzed: 20 patients (83.3%) had solid malignancies,
and 4 patients (16.7%) had hematologic malignancy such as acute myelogenous leukemia,
chronic myelogenous leukemia and plasma cell leukemia. Among 20 patients with solid
malignancies, 8 patients (37.5%) had urogenital cancers (three renal cell carcinomas among
others), 7 patients (33.3%) had skin cancers (squamous cell carcinoma and melanoma), and
5 patients had other cancers such as colorectal, breast, or lung cancer (Table 1). None of the
patients had neutropenia defined as an absolute neutrophil count less than 500 neutrophils
per microliter of blood.
The source of cultures was analyzed (Table 2). Culture specimens were obtained from a body
fluid aspirate or a wound in 12 patients (50%), 7 (29.2%) urine, four (16.7%) blood, and
one cerebrospinal fluid. Based on clinical manifestation, 14 of the 24 patients (58.3%) were
treated as a true infection, and the remainder as a contamination or colonization (10 out of
24 patients; 41.7%). In the group of patients diagnosed with a true infection, seven out of
14 (50%) were diagnosed with SSTI, one with a pelvic abscess (7%), one patient (7%) had a
catheter-associated bloodstream infection, and five patients (35.7%) had a UTI. In patients
diagnosed with a true infection, three cultures were polymicrobial. Two urine cultures grew
Table 1. General characteristics (age, gender, type of malignancy) of the patients included in the case series
All patients
True infection group
Colonization group
(N = 24)
(N = 14)
(N = 10)
Age, mean ± SD, years
60.9 ± 12.4
60.7 ± 14
61.1 ± 8.1
Gender, No.
Male
13
8
5
Female
11
6
5
Underlying malignancy
Solid tumors, No.
20
12
8
Urogenital cancer
8
5
3
Skin cancer
7
3
4
Othera
5
4
1
Hematologic malignancy, No.
4
2
2
a
Include cases of colorectal, breast, lung cancer, and dermatofibrosarcoma.
Table 2. Culture source in all patients and in the patients diagnosed with true infection
No. (%)
Number of patients
No. of patients
24 (100)
Blood, No. (%)
4 (16.7)
Urine, No. (%)
7 (29.2)
Wound or body fluid, No. (%)
12 (50.0)
CSF, No. (%)
1 (4.2)
CSF, cerebrospinal fluid.
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S. lugdunensis greater than 100,000 colonies per milliliter and lower than 10,000 colonies per
milliliter of mixed bacterial flora. An isolated blood culture from one of the two patients with
bacteremia was also polymicrobial and grew S. lugdunensis, S. epidermidis, and Bacillus species
not anthracis.
Characteristics of the patients that were diagnosed with a true infection versus colonization
group are described in Table 3 and Table 4 respectively.
Out of 14 patients that had a culture positive for S. lugdunensis, seven (50%) were diagnosed
with skin and soft tissue infection (SSTI) based on a positive wound or fluid aspirate culture
and clinical presentation in six patients. One of the seven patients diagnosed with SSTI had
polymicrobial bacteremia as described above. Polymicrobial nature of the isolated blood
culture raised a possibility of a contamination. However, the patient had a dehisced wound
with infected hardware near the thoracic spine, which was thought to be a potential source of
patient's bacteremia. Among patients with SSTI, two patients had infection at the groin site,
two in the thigh area, one in the abdominal wall, one at the prior thoracic region surgical site,
and one patient had an infection at a prior below the knee amputation site. Of note, all seven
patients with SSTIs had a prior history of surgery, such as a tumor resection, lymph node
dissection, ventral hernia repair, or kyphoplasty. The most common presentation for patients
with SSTI was pain at the surgical site in five patients, fever in three patients, purulent
drainage from the wound in one patient, erythema at the surgical site in one patient,
and wound dehiscence in one patient. All seven patients were treated with antibiotics as
described below; in addition, image-guided aspiration or drainage was utilized in five out of
seven patients. All patients improved after the treatment.
One patient was diagnosed with a deep pelvic abscess based on the clinical presentation
and a positive intraoperative deep wound culture. This patient had a history of a prior pelvic
surgery and underwent image-guided fluid drainage as described in Table 3. He was treated
with antibiotics and subsequently improved.
Four patients out of 24 in our study had blood culture samples positive for S. lugdunensis. One
patient had an intra-vascular device in place and was diagnosed with the catheter-associated
blood-stream infection. In the second patient (as described above), the likely source of
bacteremia was a spinal wound infection with infected hardware, therefore, this patient
was included in the subgroup of patients diagnosed with SSTI. Based on their chart review,
neither one of them was diagnosed with endocarditis, however, only the second patient had
an echocardiography performed at the time of the diagnosis. In that particular patient, a
transthoracic echocardiography was performed four days after bacteremia onset and was
negative for any valvular changes to suggest a diagnosis of endocarditis. The above two patients
were treated with intravenous antibiotics and improved. In the two remaining cases, blood
culture contamination was diagnosed and treatment was not prescribed due to the lack of
evidence of a clinically significant infection. Bacteremia did not re-occur in any of the patients.
Seven patients had positive urine culture for S. lugdunensis in a significant quantity, greater
than 100,000 colonies per milliliter. Five patients were diagnosed with a true infection based
on the presence of symptoms such as dysuria. As described earlier, two out of five patients
with UTI had polymicrobial urine culture with S. lugdunensis isolated in a significant range
greater than 100,000 colonies per milliliter; mixed bacterial flora was present in a nonsignificant range less than 10,000 colonies per milliliter. All five patients had significant
https://icjournal.org
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29
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Wound culture
(deep abdominal
wound)
Superficial wound
culture

Specimen

Metastatic
colorectal
cancer
Chronic
lymphocytic
leukemia

Metastatic
breast cancer

Germ cell
testicular
cancer
Renal cell
carcinoma

AML, s/p
allogeneic HSCT
Renal cell
carcinoma

Melanoma of
the buttock

Melanoma of
the thigh

Metastatic
penile cancer

Dermatofibrosarcoma

Urine culture

Urine culture

Urine culture

Urine culture

Blood culture (one
culture positive)
Blood Culture (one
culture positive,
polymicrobial)
Urine culture

Body fluid culture
(JP drain)

Body fluid aspirate
culture

Body fluid aspirate
culture

Body fluid aspirate
culture

Poorly
differentiated
chordoma of
the foot
Prostate cancer Body fluid aspirate
culture

Urothelial
cancer

Underlying
Malignancy

UTI

UTI

UTI

UTI

Groin surgical site
infection (wound
infection/cellulitis)
Bacteremia, possibly
CVC-associated
Bacteremia, from
prior surgical wound
infection/dehiscence
UTI

Left thigh abscess

Left groin fluid
collection at prior
surgical site
Left thigh fluid
collection

Below-knee
amputation site soft
tissue infection and
fluid collection
Pelvic abscess

Abdominal-pelvic
subcutaneous abscess

Diagnosis/
Possible Source

Dysuria, UA pyuria
WBC >100/hpf,
abdominal pain
Urinary retention,
UA pyuria WBC
>100/hpf
UTI symptoms, not
other specified, UA
pyuria WBC >100/
hpf
Urinary frequency,
pain with urination,
UA WBC >100/hpf
Frequent urination,
UA WBC >100/hpf

Wound dehiscence

Fever, Purulent
drainage from
wound
Fatigue, leukopenia

Fever, pain at
abscess site

Left thigh erythema
and pain

Left groin pain

Fever, chills

Pain and burning at
prior amputation
site

Fever, chills,
abdominal pain

Presentation/
Clinical Symptoms

No

No

No

No

CVC or
Other
Device

none

none

none

Left open radical
nephrectomy

None

3 months
and 27 days

1 month and
18 days

N/A

31 days

2 months
and 11 days

1 month and
29 days

23 days

2 months
and 14 days

8 months
and 26 days

28 days

Time to
Diagnosis of
Infectiona

none

none

N/A

N/A

Intermittent 26 days
straight catheterizations
Implantable N/A
port

Left ureteral
stent

Melanoma site resection No
and right groin
lymphadenectomy
None
Yes (Hickman
catheter)
Spinal instrumentation No
and fusion

Total urethrectomy,
Port
peritoneal urethrostomy,
bilateral groin lymph
node dissection
Left thigh melanoma
No
excision with groin LN
dissection

Inguinal mass resection

Robotic radical
prostatectomy

Repair of large ventral
hernia with primary
closure
Right below knee
amputation

Prior Procedures

Ciprofloxacin for 7 days

Trimethoprim-sulfamethoxazole
for 14 days

Nitrofurantoin for 14 days

Ciprofloxacin for 10 days

Ciprofloxacin for 14 days

Vancomycin IV and oral
Ciprofloxacin for 42 days

Vancomycin IV for 10 days

Vancomycin and Ampicillin/
Sulbactam for 3 days,
transitioned to oral doxycycline
on discharge for 14 more days
Amoxicillin/Clavulanate and
ciprofloxacin for 10 days

Cephalexin for 28 days

Linezolid for 14 days, followed
by Sulfamethoxazole/
Trimethoprim for 28 days
Amoxicillin/Clavulanate for
14 days

Doxycycline and Ciprofloxacin
for 14 days

Cephalexin for 14 days

Antibiotic Treatment

none

none

none

none

none

Spinal hardware
removal

CVC removal

JP drainage

CT-guided drainage of
abscess

US-guided drainage

US-guided fluid
collection aspiration

CT-guided drainage of
pelvic fluid collection

I&D of abdominal
abscesses, Wound
Vacuum placement
none

Other Treatment
Intervention

a

Duration between the date of surgical procedure performed and the date of infection occurred and culture taken.
CVC, central venous catheter; M, male; F, female; CT, computed tomography; US, ultrasound; JP, Jackson-Pratt drain; AML, acute myelogenous luekemia; s/p, status post; HSCT, hematopoietic stem
cell transplant; N/A, not applicable; UTI, urinary tract infection; UA, urinalysis; WBC, white blood cell; hpf, high-power field.

M

1

Case Gender Age

Table 3. Characteristics of the patients diagnosed with a true infection
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Table 4. Characteristics of the patients diagnosed with a colonization or contamination
Case Gender Age
Underlying
Specimen
Diagnosis/
Presentation/
malignancy
Possible
Clinical
Source
Symptoms
1
F
60 Squamous cell
Wound Colonization
Chronic
carcinoma of skin/
non-healing
hand
radiation ulcer
2
M
43 Metastatic
CSF
Contamination None
melanoma
3

M

59

Chronic lymphocytic Wound
leukemia

Colonization

Non-healing
scalp wound

4
5

M
F

69
65

Urine
Wound

Colonization
Colonization

None
Painful nodule

6

F

58

Wound

Colonization

7
8

F
M

72
58

Urine
Wound

9

M

68

Bladder cancer
Squamous cell
carcinoma of skin
Squamous cell
carcinoma of skin
Cervical cancer
Squamous cell
carcinoma of lung
Renal cell
carcinoma

10

F

59

Plasma cell
leukemia

Prior Procedures
Surgical resection
of radiation ulcer

CVC or
Other
Device
None

Intrathecal
Ommaya
cytarabine
reservoir
injection
Wound
Port
debridement, scalp
flap

Antibiotic Treatment
Not treated

Other
Treatment
Intervention
None

Not treated

None
None

None
None
None

Not treated

None

Colonization
Colonization

Cystourethroscopy
Recent excision of
cancer
Pain and
Recent excision of
erythema
cancer
Hematuria
None
Erythema of skin None

Cephalexin given postoperatively after flap
placed; wound was
not suspected to be
infected
Prophylactic Bactrim
Not treated

None
None

Not treated
Not treated

None
None

Blood

Colonization

Hypotension

None

None

None

Blood

Colonization

Fever, diarrhea,
vomiting

None

None

Vancomycin initially,
then discontinued
as culture was felt
to be contaminant,
hypotension was
attributed to volume
depletion
Vancomycin initially,
then discontinued
as symptoms were
attributed to other
diagnosis

None
None

None

CVC, central venous catheter; F, female; M, male; CSF, cerebrospinal fluid.

pyuria on urinalysis, defined as a presence of 100 or more white blood cells (WBC) per
high power field (hpf ). One patient had a ureteral stent in place and one patient used
intermittent straight catheterizations on a regular basis. All five patients received antibiotic
treatment as indicated in Table 3 and all five improved. There were two patients diagnosed
with asymptomatic S. lugdunensis bacteriuria. One of those two patients received antibiotics
(trimethoprime/sulfamethoxazole [TMP/SMX]) in view of a scheduled urologic procedure.
All 14 patients that were diagnosed with a true infection were treated with antibiotics
(Table 3). One patient diagnosed with asymptomatic S. lugdunensis bacteriuria was treated
in view of an upcoming invasive urologic procedure. The most common regimens included
ciprofloxacin in 3 (21%) patients, followed by cephalexin in 2 patients (14.3%). Other
antimicrobials such as linezolid, amoxicillin/clavulanate, sulfamethoxazole/trimethoprim,
nitrofurantoin as well as combination therapy was used as indicated in Table 3. The duration
of therapy varied from one week to 6 weeks. Both patients with bacteremia were treated with
intravenous therapy. All patient had resolution of their infectious process.
Susceptibility data confirmed that S. lugdunensis was susceptible to most of the antibiotics
except for penicillin G, which showed 100% resistance in our patient population (Table 5).
Susceptibility to oxacillin was 86.96%. For the antibiotics gentamicin, linezolid, rifampin,
synercid, tigecycline, vancomycin and nitrofurantoin, S. lugdunensis showed 100% susceptibility.
To other antibiotics, S. lugdunensis showed 80- 90% susceptibility as indicated in Table 4.
https://icjournal.org
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Table 5. Antibiotic susceptibility data
Antibiotic Type
Ciprofloxacin
Clindamycin
Erythromycin
Gentamicin
Levofloxacin
Linezolid
Oxacillin
Penicillin G
Rifampin
Synercid
Tetracycline
Tigecycline
TMP-SMX
Vancomycin
Nitrofurantoin
TMP/SMX, trimethoprim-sulfamethoxazole.

Sensitivity (%)
90.9
95.2
90.9
100
90.9
100
87.0
0
100
100
95.2
100
80
100
100

DISCUSSION
S. lugdunensis is a Gram-positive, catalase-positive, CoNS that is a part of the normal
skin flora [7]. It most commonly colonizes the perineal and groin areas of the body [7].
Although S. lugdunensis is part of CoNS group, it is considered virulent and can cause
destructive disease, therefore, isolation of this organism in culture should be taken seriously.
Immunocompromised patients may be more vulnerable; however, limited data is available on
S. lugdunensis infections in cancer patients. We performed a retrospective chart review of the
patients with positive cultures for this organism. True infection was diagnosed in 14 out of 24
patients (58.3%). Of these, 11 cultures were monomicrobial and positive only for
S. lugdunensis, and three cultures were polymicrobial as described above.
In our case series, skin and soft tissue infection was common and diagnosed in 7 patients
(50%) with clinically significant isolates for S. lugdunensis. This is consistent with prior
studies indicating that S. lugdunensis is a common pathogen of SSTI in the general population
[4, 11, 12]. A recent study characterizing S. lugdunensis infections in cancer patients from MD
Anderson Cancer Center Institute found skin and soft tissue infection in 80% of the cases
[9]. Of note, all of these patients had recent surgery or an invasive intervention in the area
where infection developed.
Four patients out of 24 in our study had blood culture samples positive for S. lugdunensis.
Clinically significant bacteremia was established in 2 patients and was treated; blood
contamination with S. lugdunensis was diagnosed in the other two patients. Even though
S. lugdunensis is a part of the normal skin flora and its isolation in blood cultures can represent
contamination, the detection of this organism even in a single blood culture should be
thoroughly evaluated as S. lugdunensis bacteremia can be associated with an aggressive
infection such as endocarditis [3, 13, 14]. A small study by Fadel et al. found that clinically
significant bacteremia occurred in 16 out of 29 (45%) patients with single S. lugdunensispositive blood cultures [15]. None of the patients in their study experienced bacteremia
relapse; no cases of endocarditis were reported either [15]. The study by Zinkernagel et al.
reported a 50% incidence of infective endocarditis in patients with S. lugdunensis bacteremia;
all of the cases with endocarditis were community-acquired [13]. Most of the other cases
of clinically significant S. lugdunensis bacteremia, especially if health-care associated, were
https://icjournal.org
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known to be associated with central venous catheters [13, 16, 17]. Of note, our study had
very few patients with underlying hematological malignancies (16.7%), whereas most
had a solid malignancy as an underlying diagnosis. This could be explained by a common
use of prophylactic antibiotics such as fluoroquinolones and TMP/SMX in patients with
hematologic malignancies and neutropenia. Both fluoroquinolones and TMP/SMX have high
activity against S. lugdunensis, potentially preventing the majority of infections caused by this
organism but not by other CoNS species in this particular patient population.
In our study, 7 patients were found to have urine cultures positive for S. lugdunensis. Five out
of seven patients were diagnosed with UTI and were treated with antibiotics. In addition, one
out of two patients in the colonized group received antibiotics due to an upcoming invasive
urologic procedure. Our study shows a much higher rate of diagnosis of S. lugdunensisassociated UTI compared to other case series. In the study by Haile et al., only 9 out of 30
patients (30%) with a urine culture positive for S. lugdunensis were thought to be clinically
significant and treated for UTI [8]. A recent article by Nesher et al. characterizing S. lugdunensis
infections in cancer patients at the MD Anderson Cancer Institute reported a very low rate
of S. lugdunensis genito-urinary infections in only 2 out of 45 patients [9]. Based on the prior
literature review, S. lugdunensis is considered an infrequent cause of UTI, despite its common
colonization of the groin and perineum.
Prior studies confirm that S. lugdunensis remains susceptible to a variety of antimicrobial
agents [1, 2]. In our study, resistance to penicillin G was universal at 100% and about 10% of
all the isolates were resistant to oxacillin. A study by Kleiner et al. reported only 1 out of 35
isolates (3%) being resistant to oxacillin [11]. Another study of Tan et al., reported only 5%
resistance to oxacillin in 106 analyzed isolated [18]. Penicillin and oxacillin resistance in our
case series appear to be higher than has been reported in the literature, likely reflecting prior
antibiotic exposure in our specific patient population.
Our case series indicate that, similar to the general population, S. lugdunensis most commonly
causes skin and soft tissue infections in cancer patients, but unlike prior studies we saw more
patients with UTIs. The incidence of clinically significant bacteremia was low with no cases
of endocarditis in our study. We observed that S. lugdunensis remains susceptible to a variety
of antibiotics, with all isolates susceptible to vancomycin and linezolid and most remain
susceptible to fluoroquinolone and TMP/SMX. The limitation of our study is its retrospective
nature and small sample size. In conclusion, S. lugdunensis, an organism that belongs to CoNS
group, has a tendency to cause clinically significant and even aggressive infections, compared
to other CoNS species. However, none of our patients had life-threatening infections and all
recovered with appropriate antibiotic therapy.
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